Astrazeneca advertisement
Advertisement: PwC mid banner
Advertisement: Barclays Corporate
Advertisement: TTP
Advertisement: Bailey Fisher
Advertisement: Cambridge Enterprise
St Johns Innovation Centre
Mills-Reeve
Advertisement: Cambridge Science Park
10 September, 2018 - 12:19 By News Desk

Shaun Grady – AstraZeneca

Shaun Grady is Vice-President Business Development Operations, leading AstraZeneca’s transaction execution, due diligence and Alliance and Integration Management function. This includes late-stage as well as on-market licensing and partnering, M & A, and divestments.

His career background includes roles at ICI, Zeneca, and AstraZeneca in Corporate, Pharmaceuticals and US Legal departments, HR and Business Development.

Shaun has worked on major projects including the AstraZeneca merger, creation of Avecia and Syngenta, acquisition of Cambridge Antibody Technology (CAT), MedImmune and Amylin, and the spin out of Albireo. He is also a board member at Healx in Cambridge, which repurposes drugs to treat rare diseases.

Newsletter Subscription

Stay informed of the latest news and features